Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-049127
Filing Date
2021-08-02
Accepted
2021-08-02 19:44:18
Documents
1
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 6147
  Complete submission text file 0001209191-21-049127.txt   7527
Mailing Address BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234
Business Address
Nanavaty Maulik (Reporting) CIK: 0001529708 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-40672 | Film No.: 211137421

Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Issuer) CIK: 0001856725 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations